Cas 684243-48-9,1H-1,4-Diazepine, 1-(cyclopentylcarbonyl)hexahydro-4-[[4-[3-(1-piperidinyl)propoxy]phenyl] methyl]-

684243-48-9

Post Buying Request

Basic information

Product Name: 1H-1,4-Diazepine, 1-(cyclopentylcarbonyl)hexahydro-4-[[4-[3-(1-piperidinyl)propoxy]phenyl] methyl]-
Synonyms:
CAS NO:684243-48-9
Molecular Formula: C26H41N3O2
Molecular Weight: 427.63
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1H-1,4-Diazepine, 1-(cyclopentylcarbonyl)hexahydro-4-[[4-[3-(1-piperidinyl)propoxy]phenyl] methyl]-(CAS DataBase Reference)
NIST Chemistry Reference: 1H-1,4-Diazepine, 1-(cyclopentylcarbonyl)hexahydro-4-[[4-[3-(1-piperidinyl)propoxy]phenyl] methyl]-(684243-48-9)
EPA Substance Registry System: 1H-1,4-Diazepine, 1-(cyclopentylcarbonyl)hexahydro-4-[[4-[3-(1-piperidinyl)propoxy]phenyl] methyl]-(684243-48-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 684243-48-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

684243-48-9 Suppliers

Recommended suppliers

684243-48-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 684243-48-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,4,2,4 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 684243-48:
(8*6)+(7*8)+(6*4)+(5*2)+(4*4)+(3*3)+(2*4)+(1*8)=179
179 % 10 = 9
So 684243-48-9 is a valid CAS Registry Number.

684243-48-9Upstream product

684243-48-9Downstream Products

684243-48-9Relevant academic research and scientific papers

SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS

-

Page 30-31, (2008/06/13)

The present invention relates to novel piperazine and azepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurodegenerative disorders including Alzheimer's disease.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 684243-48-9